drugset / Trial / NCT00036036
Study of CP-461 in Patients With Advanced Renal Cell Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the efficacy of CP-461 given twice-daily orally in locally advanced or metastatic renal cell cancer and to evaluate the safety profile of CP-461 in this patient population.
Timeline
- Start
- 2001-07
- Primary completion
- —
- Completion
- 2003-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CP-461 | Small molecule | — | Oral |